Dong Oh Kang
Latest contributions
DCB and latest DES technology for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
Complex coronary artery disease: how to use intracoronary imaging in daily practice challenges?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with various cardiology societies, focuses on the use of intracoronary imaging to optimize percutaneous coronary intervention (PCI) in complex coronary artery disease. It presents case studies demonstrating the role of imaging-based assessment of coronary calcified lesions, the importance of a standardized imaging...
DCB PCI in restenosis and de novo lesions
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...
